Hi
Looks like we are the only 2 people using this forum with an interest in stocks which go up and stay up, atleast over the longer term. Hope you got your coh at 54 if you did you will be pleased with their results to day I have them on a valuation of between $70 and $75 for fy08. I have been investing in coh forthe last 4 years, originally got in at $24, missed out on their low point of appx 18.80. I will probably hold them for atleast another 2 years since I like both the product and Chris Roberts.
Are you a value investor?
Hi
Looks like we are the only 2 people using this forum with an interest in stocks which go up and stay up, atleast over the longer term. Hope you got your coh at 54 if you did you will be pleased with their results to day I have them on a valuation of between $70 and $75 for fy08. I have been investing in coh forthe last 4 years, originally got in at $24, missed out on their low point of appx 18.80. I will probably hold them for atleast another 2 years since I like both the product and Chris Roberts.
Are you a value investor?
Credit Suisse via FNArenaCochlear has received a warning letter from the US Food and Drug Administration (FDA) relating to its Bone Anchored Solutions (BAS) division’s operations in Gothenburg Sweden - an import alert has been instituted prohibiting the distribution of BAHA products into the US. This had already been flagged as a possibility by the company.
Citi via FNArenaThe broker has reviewed FDA's Section 520(f) relating to the warning letter received by the company banning admission of Baha products into the US and noted that it does not address issues relating to the safety or effectiveness of the device but rather the facilities and controls around manufacturing practices.
$A v $US nearing parity is hurting profits. Same as CSL. Usually affects all companies which earn most of their money overseas in $US. Nothing abnormal or unusual about it.
Date: 20/2/2008
Author: Fiona Tyndall
Source: The Australian Financial Review --- Page: 35
Australian hearing device maker, Cochlear, expects to meet its earnings forecastfor 2007-08. It has posted revenue of $A298 million for the six months to 31December 2007, a rise of eight per cent. Its sales in the US were lower thanexpected, prompting a fall in its share price. Analysts believe that thecompany's prospects are good, but there is not likely to be any trigger toimprove its share price in the short-term
Date: 14/2/2008
Author:
Source: The Australian Financial Review --- Page: 34
The Australian dollar was fetching $US0.9040 early in European trading on 13February 2008, compared with $US0.9038 previously. The currency peaked at$US0.9085 amid reports that billionaire Warren Buffett may underwrite several USbond insurers. The dollar was also bolstered by growing speculation that therewill be another increase in Australian interest rates in March. The 15 per centrise in the value of the currency in the last year has affected the earnings oflisted companies such as Cochlear, which has a significant presence in overseasmarkets
Keeps on falling . No reason in my mind to explain that. Closed under $45 which is a bit worrying. Having said that COH is getting very close to a very very low RSI so will probably bounce back from the sell off that I am assuming will happen tomorrow. Might be a good buying day tomorrow
Hi yeah a bit too expenseive still, $40 is about right i think
Earnings and Dividends Forecast (cents per share)
2007 2008 2009 2010
EPS 180.1 213.7 249.8 282.5
DPS 125.0 149.5 173.7 194.5
thx
MS
Looks like EPS is forecast to grow until 2010 so looks good to me and probably a bit of a defensive stock as well. Interesting that it is almost half the price of its all time high around $80. I can't see why COH would not bounce back at some stage. I think it is being dragged down by the current bearish sentiment
Thanks for that update. Dropping again today. The RSI says screaming buy in my opinion. The problem with stock in a downtrend is to know when it will stop.
I still believe COH is a very good stock with high growth potential but short term bad news.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?